Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...
It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...
Where you live in Maryland will likely affect your quality of care if you are diagnosed with Alzheimer’s disease, according ...
Clinical Trials Arena on MSN
Spinogenix’s Alzheimer’s drug touts disease-modifying potential in Phase IIa study
If approved, tazbentetol could become the first Alzheimer’s therapy to target synaptic degradation.
A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...
Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.
High levels of calcium are toxic to cells and contribute to loss of neurons in Alzheimer’s disease. Researchers found that a ...
MedPage Today on MSN
Alzheimer's benefits may continue after donanemab treatment ends, data suggest
Patients who completed treatment by 12 months fared better than external controls 2 years ...
A new statewide spatial analysis of Alzheimer's disease and related dementias (ADRD) has uncovered significant disparities in ...
The locus coeruleus (LC) — a tiny, ancient brainstem structure that regulates arousal, attention and memory—plays a far more ...
UD's DementiaBank outshines global competitors, driving machine-learning advances in early dementia prediction ...
NEW JERSEY -- U.S. Sen. Andy Kim of New Jersey is opening up about his father's Alzheimer's diagnosis and his journey to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results